Cargando…

Malignant Infantile Osteopetrosis: A Case Report

Osteopetrosis is a rare genetic disease of bone resorption. It includes a variety of hereditary skeletal disorders that have the main radiographic feature of increased bone density and thickness due to differentiation or functional defects in osteoclast. The clinical presentation varies widely based...

Descripción completa

Detalles Bibliográficos
Autores principales: Bubshait, Dalal K, Himdy, Ziyad E, Fadaaq, Ola, Alshmas, Hajar I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984186/
https://www.ncbi.nlm.nih.gov/pubmed/32015934
http://dx.doi.org/10.7759/cureus.6725
_version_ 1783491613710876672
author Bubshait, Dalal K
Himdy, Ziyad E
Fadaaq, Ola
Alshmas, Hajar I
author_facet Bubshait, Dalal K
Himdy, Ziyad E
Fadaaq, Ola
Alshmas, Hajar I
author_sort Bubshait, Dalal K
collection PubMed
description Osteopetrosis is a rare genetic disease of bone resorption. It includes a variety of hereditary skeletal disorders that have the main radiographic feature of increased bone density and thickness due to differentiation or functional defects in osteoclast. The clinical presentation varies widely based on the type of osteopetrosis and ranges in severity from asymptomatic to a fatal course. Our case is of the infantile malignant osteopetrosis (IMOP) form. It is inherited as an autosomal recessive pattern that generally starts in intrauterine life and manifests at birth or early childhood. It is the most severe form and has an incidence of 1 in 250,000 births. The patient presented at the age of two months with a history of recurrent fever, recurrent pneumonia, developmental delay, and infantile spasms. Upon examination, she was found to have hepatosplenomegaly, axial hypotonia, limb spasticity, and visual impairment. Genetic testing revealed a homozygous variant of OSTM1 gene, which is a known Saudi mutation of autosomal recessive osteopetrosis (ARO). IMOP should be considered as a rare differential of hepatosplenomegaly. Early diagnosis by clinical picture, imaging, and genetic testing is important to direct the appropriate management in order to prevent disease progression before the irreversible neurological sequelae occur. Patients should be managed by a comprehensive approach, and currently, hematopoietic stem cell transplantation (HSCT) provides a better outcome for IMOP patients.
format Online
Article
Text
id pubmed-6984186
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-69841862020-02-03 Malignant Infantile Osteopetrosis: A Case Report Bubshait, Dalal K Himdy, Ziyad E Fadaaq, Ola Alshmas, Hajar I Cureus Genetics Osteopetrosis is a rare genetic disease of bone resorption. It includes a variety of hereditary skeletal disorders that have the main radiographic feature of increased bone density and thickness due to differentiation or functional defects in osteoclast. The clinical presentation varies widely based on the type of osteopetrosis and ranges in severity from asymptomatic to a fatal course. Our case is of the infantile malignant osteopetrosis (IMOP) form. It is inherited as an autosomal recessive pattern that generally starts in intrauterine life and manifests at birth or early childhood. It is the most severe form and has an incidence of 1 in 250,000 births. The patient presented at the age of two months with a history of recurrent fever, recurrent pneumonia, developmental delay, and infantile spasms. Upon examination, she was found to have hepatosplenomegaly, axial hypotonia, limb spasticity, and visual impairment. Genetic testing revealed a homozygous variant of OSTM1 gene, which is a known Saudi mutation of autosomal recessive osteopetrosis (ARO). IMOP should be considered as a rare differential of hepatosplenomegaly. Early diagnosis by clinical picture, imaging, and genetic testing is important to direct the appropriate management in order to prevent disease progression before the irreversible neurological sequelae occur. Patients should be managed by a comprehensive approach, and currently, hematopoietic stem cell transplantation (HSCT) provides a better outcome for IMOP patients. Cureus 2020-01-21 /pmc/articles/PMC6984186/ /pubmed/32015934 http://dx.doi.org/10.7759/cureus.6725 Text en Copyright © 2020, Bubshait et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Genetics
Bubshait, Dalal K
Himdy, Ziyad E
Fadaaq, Ola
Alshmas, Hajar I
Malignant Infantile Osteopetrosis: A Case Report
title Malignant Infantile Osteopetrosis: A Case Report
title_full Malignant Infantile Osteopetrosis: A Case Report
title_fullStr Malignant Infantile Osteopetrosis: A Case Report
title_full_unstemmed Malignant Infantile Osteopetrosis: A Case Report
title_short Malignant Infantile Osteopetrosis: A Case Report
title_sort malignant infantile osteopetrosis: a case report
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984186/
https://www.ncbi.nlm.nih.gov/pubmed/32015934
http://dx.doi.org/10.7759/cureus.6725
work_keys_str_mv AT bubshaitdalalk malignantinfantileosteopetrosisacasereport
AT himdyziyade malignantinfantileosteopetrosisacasereport
AT fadaaqola malignantinfantileosteopetrosisacasereport
AT alshmashajari malignantinfantileosteopetrosisacasereport